Literature DB >> 17277585

Physical activity, diet, and incident diabetes in relation to an ADRA2B polymorphism.

David E Laaksonen1, Niina Siitonen, Jaana Lindström, Johan G Eriksson, Piritta Reunanen, Jaakko Tuomilehto, Matti Uusitupa.   

Abstract

PURPOSE: The 12Glu9 polymorphism of the alpha2B-adrenergic receptor gene may impair insulin secretion and modify the effects of a lifestyle intervention on the risk of type 2 diabetes, but the interaction with specific lifestyle components is unknown. We assessed the associations of leisure-time physical activity (LTPA), dietary changes, and weight loss on the risk of type 2 diabetes according to the 12Glu9 polymorphism in 481 participants of the Finnish Diabetes Prevention Study. METHODS AND
RESULTS: The lifestyle intervention decreased the risk of diabetes in 9Glu carriers (9Glu9, intervention vs control, relative risk (RR) = 0.23, 95% confidence interval (CI) 0.09-0.62), but not in 12Glu12 homozygotes. In the combined intervention and control groups, increased total LTPA as estimated with a questionnaire decreased the risk of diabetes in 12Glu carriers (12Glu12, upper vs lower third, RR = 0.12, 95% CI 0.03-0.53) but not in 9Glu9 homozygotes (P for the interaction 0.033). In contrast, favorable dietary changes, estimated using a dietary score, reduced the risk of diabetes in those with the 9Glu9 genotype (upper vs lower third, RR = 0.21, 95% CI 0.06-0.75) but not in those with the 12Glu allele. Weight loss significantly decreased the risk of diabetes only in 12Glu carriers.
CONCLUSION: Increased LTPA decreased the risk of type 2 diabetes more in those with the 12Glu allele of the ADRA2B gene, whereas dietary changes may have mediated the greater risk reduction of the lifestyle intervention in 9Glu homozygotes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17277585     DOI: 10.1249/01.mss.0000246998.02095.bf

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  8 in total

Review 1.  Prevention of type 2 diabetes: the strategic approach for implementation.

Authors:  P E H Schwarz; A L Albright
Journal:  Horm Metab Res       Date:  2011-12-07       Impact factor: 2.936

Review 2.  The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives.

Authors:  Lei Chen; Dianna J Magliano; Paul Z Zimmet
Journal:  Nat Rev Endocrinol       Date:  2011-11-08       Impact factor: 43.330

Review 3.  Personalized medicine in diabetes mellitus: current opportunities and future prospects.

Authors:  Jeffrey W Kleinberger; Toni I Pollin
Journal:  Ann N Y Acad Sci       Date:  2015-04-23       Impact factor: 5.691

Review 4.  The Genetic Architecture of Diabetes in Pregnancy: Implications for Clinical Practice.

Authors:  Jeffrey W Kleinberger; Kristin A Maloney; Toni I Pollin
Journal:  Am J Perinatol       Date:  2016-08-29       Impact factor: 1.862

5.  Impaired desensitization of a human polymorphic α2B-adrenergic receptor variant enhances its sympatho-inhibitory activity in chromaffin cells.

Authors:  Kristy Nguyen; Theodoros Kassimatis; Anastasios Lymperopoulos
Journal:  Cell Commun Signal       Date:  2011-02-07       Impact factor: 5.712

Review 6.  Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum.

Authors:  William T Cefalu; John B Buse; Jaakko Tuomilehto; G Alexander Fleming; Ele Ferrannini; Hertzel C Gerstein; Peter H Bennett; Ambady Ramachandran; Itamar Raz; Julio Rosenstock; Steven E Kahn
Journal:  Diabetes Care       Date:  2016-06-09       Impact factor: 19.112

7.  Dietary and genetic risk scores and incidence of type 2 diabetes.

Authors:  Ulrika Ericson; George Hindy; Isabel Drake; Christina-Alexandra Schulz; Louise Brunkwall; Sophie Hellstrand; Peter Almgren; Marju Orho-Melander
Journal:  Genes Nutr       Date:  2018-05-16       Impact factor: 5.523

8.  Gene-lifestyle interaction on risk of type 2 diabetes: A systematic review.

Authors:  Stefan Dietrich; Simone Jacobs; Ju-Sheng Zheng; Karina Meidtner; Lukas Schwingshackl; Matthias B Schulze
Journal:  Obes Rev       Date:  2019-09-02       Impact factor: 9.213

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.